A drug‐naive SCN1A Dravet syndrome mouse model demonstrated impaired sleep homeostasis secondary to the loss of Nav1.1 channels in the inhibitory forebrain GABAergic neurons, implicating the gene's involvement in sleep disruption.42 The gene discussed is SCN1A; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.